VISHEE(SH:688580) Zhong Guo Jing Ji Wang·2026-01-19 07:31Core Viewpoint - The announcement from Weisi Medical (688580.SH) reveals that shareholder Nanjing Zhida Venture Capital Center plans to reduce its stake in the company by up to 2,873,137 shares, representing a maximum of 3% of the total share capital, without significantly impacting the company's governance or operational stability [1][2]. Shareholder Reduction Plan - Nanjing Zhida Venture Capital intends to reduce its holdings through two methods: a maximum of 957,712 shares via centralized bidding (1% of total shares) and up to 1,915,425 shares through block trading (2% of total shares), both within three months after 15 trading days from the announcement date [1][2]. - The total cash-out from the planned reduction is approximately ¥180,605,391.82, based on the closing price of ¥62.86 per share on January 16 [2]. Company Background - Weisi Medical was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 21, 2020, with an initial issuance of 17.0867 million shares at a price of ¥67.58 per share, raising a total of ¥1.155 billion [2]. - The net proceeds from the fundraising amounted to ¥1.063 billion, exceeding the original plan by ¥596 million, which was intended for various projects including R&D and marketing [2]. Shareholder Structure - As of the announcement date, Nanjing Zhida Venture Capital held 6,758,338 shares, accounting for 7.06% of the total share capital, and is in a concerted action relationship with the company's actual controller, Wang Zhiyu [2][4]. - Wang Zhiyu is the executive partner of Nanjing Zhida Venture Capital and holds Canadian permanent residency [4]. Dividend Distribution - The company plans to distribute a cash dividend of ¥1.5032 per share (including tax) and to increase the share capital by 4 shares for every 10 shares held, based on the total share capital after accounting for repurchased shares [4][5]. - The total cash dividend distribution is expected to be approximately ¥102,194,339.48 (including tax), with the adjusted per-share cash dividend amounting to ¥1.5058 [5].